1 / 45

MERCURY and THE IMMUNE SYSTEM: OLD WINE IN NEW BOTTLES?

MERCURY and THE IMMUNE SYSTEM: OLD WINE IN NEW BOTTLES? . ELLEN SILBERGELD JOHNS HOPKINS SCHOOL OF PUBLIC HEALTH DEPARTMENT OF ENVIRON HEALTH SCIENCES SPRING 2005 MEETING AE-SOT PITTSBURGH. ACKNOWLEDGEMENTS. STUDENTS and COLLEAGUES Prof Donna Mergler, UQAM Dr Jennifer Sass, NRDC

MikeCarlo
Télécharger la présentation

MERCURY and THE IMMUNE SYSTEM: OLD WINE IN NEW BOTTLES?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MERCURY and THE IMMUNE SYSTEM: OLD WINE IN NEW BOTTLES? ELLEN SILBERGELD JOHNS HOPKINS SCHOOL OF PUBLIC HEALTH DEPARTMENT OF ENVIRON HEALTH SCIENCES SPRING 2005 MEETING AE-SOT PITTSBURGH

  2. ACKNOWLEDGEMENTS • STUDENTS and COLLEAGUES • Prof Donna Mergler, UQAM • Dr Jennifer Sass, NRDC • Dr Peter Crompton, Harvard • Ines Silva, Univ of Michigan • Dr Jennifer Nyland, Dr Noel Rose, Dr DeLisa Fairweather, Johns Hopkins • Dr Charles Via, Dr John Sacci, Dr G T Strickland, Univ Maryland • Dr Emma Calderon Aranda, CINVESTAV – Mexico • Dr Jose Maria de Souza, Dr Ana Maria Ventura, Dr Elisabeth Santos, Ms Iracina de Jesus FNS-IEC -- Brazil

  3. FUNDING • NATIONAL INSTITUTES OF HEALTH • PAN AMERICAN HEALTH ORGANIZATION • ARTHRITIS FOUNDATION • AMERICAN HEART ASSOCIATION • CURE AUTISM NOW FOUNDATION

  4. MERCURY IN THE ENVIRONMENT • INCREASINGLY RECOGNIZED AS A GLOBAL POLLUTANT (UNEP, WHO) • MAJOR ENVIRONMENTAL RISK TO CHILDREN’S HEALTH (EPA, WHO, CEC) • CRITICAL EFFECT - DEVELOPMENTAL NEUROTOXICITY (WHO, NAS) • FISH CONSUMPTION MAJOR ROUTE OF HUMAN EXPOSURE TO MeHg • AIRBORNE Hg EXPOSURES? • MERCURY EXPOSURES CONTINUE IN WORKPLACES

  5. THE CONTINUING PROBLEM OF METHYL MERCURY IN FISH: HOW MUCH METHYLMERCURY IS THERE IN TUNA? • 0.5-1.0 ppm CONSIDERED “SAFE” (EPA/FDA) • 2-10 ppm FISH CONSUMPTION CAUSES PROBLEMS • 10 ppm = 10 ug/gm; • In 6 oz ≈ 1.8 mg • FOR A 70 KG PERSON, DOSE = 26 ug/kg

  6. MERCURY RISKS and CAUGHT FISH CONSUMPTION

  7. MERCURY HAZARDS are LOCAL, REGIONAL and GLOBAL

  8. TOXIC EFFECTS OF MERCURY COMPOUNDS • NEUROTOXICITY • DEVELOPMENTAL EFFECTS (NRC, WHO) • ADULTS MAY BE AS SENSITIVE • NEPHROTOXICITY • DERMATOTOXICITY • IMMUNOTOXICITY?

  9. HOW ARE IMMUNOTOXIC MECHANISMS INVOLVED in MERCURY TOXICITY • NEPHROPATHY – IMMUNE COMPLEX (GBMP Abs) • NEUROTOXICITY – INHIBITION OF NEURAL MIGRATION [DEV, NEURODEGEN DISEASE] • IMMUNE SUPPRESSION • AUTOIMMUNE DYSFUNCTION

  10. IMMUNOLOGIC MECHANISMS ARE INVOLVED IN DEVELOPMENTAL NEUROTOXICITY OF MERCURY (Sass et al 2001; Calderon et al in press) • Mercury induces glial activation • Microglia are macrophage lineage cells • Microglia direct neuronal migration through cytokine/chemokine/CAM pathways Developmental mercury exposure affects these signaling pathways • signal transduction events in cerebellar cell cultures from neonatal mice • altered gene expression, cytokine production, and cellular protein levels

  11. AUTOIMMUNE DISEASE • COMPLEX DISORDERS (ORGAN SPECIFIC and SYSTEMIC) • BASIC MECHANISM: FAILURE TO RECOGNIZE “SELF” • RISK FACTORS INCLUDE GENETICS and ACQUIRED EXPOSURES • STRONG SEX BIAS IN DISEASE INCIDENCE AND SEVERITY • GEOGRAPHIC PATTERNS OF DISEASE • POORLY MANAGED, INCURABLE DISEASES

  12. AUTOIMMUNE DISEASE – A WOMEN’S HEALTH ISSUE

  13. MERCURY AND AUTOIMMUNE DISEASE • CAN MERCURY CAUSE AI DISEASE? • HUMAN DATA? • NEPHROTOXICITY MAY INVOLVE AUTOIMMUNE MECHANISMS • FRANK AI DISEASE NOT DEMONSTRATED IN OCC STUDIES BUT EPI DATA ARE LIMITED • NEUROTOXICITY MORE SENSITIVE OUTCOME • EXPERIMENTAL DATA – YES • INBRED RODENT STRAINS ARE SUSCEPTIBLE • RESPONSE CAN INCLUDE AUTOANTIBODIES, VASCULITIS, NEPHROPATHY • DOSES ARE RELATIVELY HIGH

  14. MERCURY and HUMAN AUTOIMMUNE DISEASE: THE LATEST STUDY! • CAROLINA LUPUS STUDY • CASE:CONTROL (265:355) • CASES: 90% FEMALE, 60% AFRICAN AMERICAN • INCREASED ODDS FOUND FOR: • OCCUPATIONAL EXPOSURES TO MERCURY • EMPLOYMENT AS DENTAL TECHNICIAN • MIXING PESTICIDES (NOT IDENTIFIED) Cooper et al J Rheumatol 2004: 31: 1928-1933

  15. CAN MERCURY ACCELERATE AI DISEASE? [the BASF approach]* EXPERIMENTAL DATA • Hg accelerates pathology in lupus-prone strains of mice (NZB, BXB) • Hg accelerates disease in Graft Versus Host model of LUPUS, Cardiac Myosin model of autoimmune myocarditis and cardiomyopathy (Via et al 2003; Nyland et al 2003, 2004) *“WE DON’T CAUSE DISEASE; WE JUST MAKE IT WORSE”

  16. Hg and GVHD/LUPUS • The model: C57Bl/6 x DBA/2 – F1 • DBA/2 females + B6D2-F1 pretreated with iHg, 20 or 200 mcg/kg a.d. for 15 da. • Transfer maternal splenocytes (100 cells) • Chronic SLE-like disease develops over 18-20 months • Signs include: proteinuria, tubular nephropathy, vascular damage, autoABs [anti-ss-DNA; ANA]

  17. GVHD/SLE: iHg accelerates death

  18. Hg ACCELERATES AUTOIMMUNE NEPHROPATHY

  19. Hg increases serum antinuclear antibodies - GVHD +/- Hg

  20. Hg increases serum anti-SS DNA antibodies

  21. Hg and Autoimmune Myocarditis • AM leading cause of sudden cardiac failure in young; post-infection autoimmune disease • BALB/c female mice pretreated with iHg 10, 20, 100 or 200 μg/kg a.d. for 15 da • EAM induced by injecting antigen [cardiac myosin peptide (CMP)] + CFA + pertussis toxin or by infection with Coxsackie B3 virus • CMP – by 30 da, cardiomyopathy develops characterized by cardiac enlargement, arrhythmias, IgG1/2 [antiCMP ABs]; • CB3V – after infection and viral clearance, CM develops by 35 da

  22. Murine model of myocarditis used • CB3 virus-induced model (BALB/c) • not susceptible to iHg-induced autoimmune disease Acute phase Chronic phase

  23. CARDIOMYOPATHY +/- MERCURY: Hg exposure prior to antigenPREVALENCE 50% 77% 92% 0 A/J male mice EAM alone EAM + iHg10 EAM + iHg100 iHg100 alone

  24. iHg treatment prior to CB3V infection increases myocarditis ** *

  25. HISTOPATHOLOGY OF EXPERIMENTAL AUTOIMMUNE MYOCARDITIS: Control + CB3V Hg + CB3V

  26. CAN WE FIND BIOMARKERS OF Hg-INDUCED AUTOIMMUNITY IN HUMANS? • INCONSISTENT FINDINGS IN WORKERS, BUT ONLY STUDIES OF MEN EXPOSED TO iHG • NO FRANK AUTOIMMUNE DISEASE ASSOCIATIONS • RELATIVELY NONSPECIFIC MARKERS USED – IMMUNOGLOBULINS, CELL SUBSETS

  27. OUR STUDY: Hg exposures and autoimmunity in gold workers • POPULATION – ARTISANAL GOLD MINERS and RIVERINE POPULATIONS • LOCATION – AMAZONIAN BRAZIL • CENSUS BASED SAMPLE and CONVENIENCE SAMPLE (98; 132) • Hg EXPOSURE BIOMARKERS (HAIR and URINE) • HEALTH/OCCUP-RES-DIET INFO by QUESTIONNAIRE, CLINICAL EXAM • SERUM COLLECTIONS

  28. Small (Artisanal) scale mining: major exposures to elemental, inorganic, and methyl mercury • World wide activity – 2 to 6 million persons • Women and children • Hazardous conditions • Toxic chemicals • Illegal, unregulated • Regional, national, transboundary impacts

  29. AIRBORNE MERCURY LEVELS in GARIMPOS in LATIN AMERICA –WHO guidance <0.01 mg/m3 • Levels near amalgam burning in garimpos >100 • Levels in camps - 0.03-10 • Levels near gold shops in towns >20

  30. ARTISANAL GOLD MINING: AMAZONIA TAPAJÓS WATERSHED, PARÁ BRAZIL

  31. DEFORESTATION: Rio Rato, Tapajos

  32. HYDRAULIC MINING - garimpo RIO RATO, TAPAJOS

  33. AMALGAMATION WITH MERCURY

  34. BURNING THE AMALGAM AT THE GARIMPO

  35. CHILD LABOR IN ARTISANAL MINING

  36. Hg EXPOSURES IN GOLD MINERS – BRAZILBLOOD Hg LEVELS

  37. A) B) AUTOANTIBODIES (ANA, ANoA) IN PERSONS EXPOSED TO INORGANIC Hg C) E) F)

  38. IS ANTIFIBRILLARIN A BIOMARKER OF Hg AUTOIMMUNITY in HUMANS?

  39. CONCLUSIONS • Hg is immunotoxic, affecting host response to infections, susceptibility to autoimmune disease, and acting on immune mechanisms in target organ disease • The immunotoxic effects of Hg in animals are the lowest dose/effects yet described (0.4 μg/kg)… • There may be genetic susceptibility factors for Hg immunotoxicity • Hg may play a contributing role in the incidence and severity of autoimmune disease • DO WE NEED TO RE-ASSESS THE RISKS OF MERCURY, ESP FOR ADULTS?

  40. A CONCEPTUAL MODEL FOR Hg AND AUTOIMMUNITY (Step 1)

  41. A CONCEPTUAL MODEL FOR Hg AND AUTOIMMUNITY (Step 2)

  42. A CONCEPTUAL MODEL FOR Hg AND AUTOIMMUNITY (Step 1 + 2 = 3)

  43. IF MERCURY IS ASSOCIATED WITH AUTOIMMUNE DISEASE… • WHAT ARE THE CRITICAL EXPOSURE BIOMARKERS • CHRONIC, CURRENT? • INORGANIC AS WELL AS ORGANIC? • LATENCIES BETWEEN EXPOSURE/OUTCOME? • DOES HG AFFECT THE DEVELOPING IMMUNE SYSTEM • YES…IN MICE • HOW WOULD WE STUDY THIS? • AUTOIMMUNE DISEASES ARE RARE • CASE:CONTROL? ENRICHED POPULATIONS? • ARE THERE SUSCEPTIBLE SUBPOPULATIONS? • PERSONS FROM AI DISEASE FAMILIES • PERSONS WITH SPECIFIC GENETIC POLYMORPHISMS • WOMEN

  44. PRENATAL MERCURY EXPOSURE AFFECTS IMMUNODEVELOPMENT [Silva et al 2005] Note: inorganic Hg was used; some similar effects observed with MeHg

  45. MERCURY and ASD • Do mercury compounds CAUSE or CONTRIBUTE to ASD? • Epidemiological studies are needed • Are the mechanisms of mercury toxicity relevant as MODELS (not necessarily as CAUSES) of the mechanistic processes in ASD? • Examples: APO E -/- mouse and Alzheimers; 6-OHDA and Parkinsonism

More Related